Mayne Pharma Group (AU:MYX) has released an update.
Mayne Pharma Group Limited has announced the issuance of 34,707 performance rights under its employee incentive scheme, with these securities being unquoted and subject to transfer restrictions until a specified date. The rights were issued on September 6, 2024, as per the company’s latest announcement on September 13, 2024. The financial community may be interested in this development as it reflects the company’s ongoing commitment to employee performance-based incentives.
For further insights into AU:MYX stock, check out TipRanks’ Stock Analysis page.
